Viral vector gene therapy is a promising technique for introducing therapeutic payloads into human cells to treat previously uncurable diseases. To deliver high quality products at a commercial scale, developers need robust, scalable manufacturing processes and analytical technologies. With more than 20 years of experience in manufacturing viral gene therapy products, Lonza can provide the support needed to develop a phase-appropriate, commercially viable manufacturing process for viral vector manufacturing.
Learn More